Graftys SA-医療機器分野:企業M&A・提携分析

◆英語タイトル:Graftys SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011692
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Graftys SA (Graftys) is a medical device company that focuses on the development, manufacture and commercialization of synthetic bioactive orthopedic biomaterials. It provides a wide range of synthetic and bioresorbable bone graft substitutes and other cement products. The company’s products find application in bone reconstructive and trauma surgery; fracture repair, complex fractures, tibial osteotomy and joint arthroplasty, among others. It works in partnership with research institutions in France for the development of its product pipeline. The company’s research platform focuses on the development of orthopedic, trauma, spine and dental devices for various indications. The company has a presence in France and the US. Graftys is headquartered in Aix-en-Provence, France.

Graftys SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Graftys SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Graftys SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Graftys SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Graftys SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Graftys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Graftys SA, Medical Equipment, Deal Details 10
Venture Financing 10
Graftys Secures US$5.3 Million In Third Venture Financing Round 10
Partnerships 11
Arthrex Enters Into Co-Development Agreement With Graftys 11
Smith & Nephew Orthopaedics Enters Into Distribution Agreement With Graftys 12
Graftys SA – Key Competitors 13
Graftys SA – Key Employees 14
Graftys SA – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Mar 31, 2016: GRAFTYS strengthens its management and operations 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Graftys SA, Medical Equipment, Key Facts 2
Graftys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Graftys SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Graftys SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Graftys SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Graftys SA, Deals By Market, 2011 to YTD 2017 8
Graftys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Graftys Secures US$5.3 Million In Third Venture Financing Round 10
Arthrex Enters Into Co-Development Agreement With Graftys 11
Smith & Nephew Orthopaedics Enters Into Distribution Agreement With Graftys 12
Graftys SA, Key Competitors 13
Graftys SA, Key Employees 14

★海外企業調査レポート[Graftys SA-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suzlon Energy Ltd (SUZLON):電力:M&Aディール及び事業提携情報
    Summary Suzlon Energy Ltd (Suzlon) is a provider of renewable energy solutions. It offers total solutions package that covers the entire wind energy projects scope. The company provides complete turnkey solutions from design to lifecycle asset management. Suzlon also generates electricity; and sells …
  • The Swatch Group Ltd:企業の戦略・SWOT・財務情報
    The Swatch Group Ltd - Strategy, SWOT and Corporate Finance Report Summary The Swatch Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PZ Cussons Plc:企業の戦略・SWOT・財務分析
    SummaryPZ Cussons Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • KIM Eng Holdings Ltd.の企業概要及び財務/SWOT分析
    KIM Eng Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly …
  • Xizang Haisco Pharmaceutical Group Co Ltd (002653):企業のM&A・提携動向(医療分野)
    Summary Xizang Haisco Pharmaceutical Group Co Ltd (Haisco Pharma) is a pharmaceutical company that researches and develops new therapeutics in the areas of parenteral nutrition, anti-infectious and hepatobiliary diseases. Its product portfolio comprise injection for trace elements, compound vitamin, …
  • Grainger Plc (GRI):企業の財務・戦略的SWOT分析
    Grainger Plc (GRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Continental Wind Partners LLC:企業のM&A・提携動向(発電分野)
    Summary Continental Wind Partners LLC (Continental Wind) is a renewable energy company that develops on-shore wind energy projects. The company offers project development services including construction, operation, development and design, and procurement and financing, among others. It provides cons …
  • Commonwealth Bank of Australia:企業の戦略・SWOT・財務情報
    Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report Summary Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • BASF SE (BAS):電力:M&Aディール及び事業提携情報
    Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, e …
  • Resolute Energy Corporation (REN):企業のM&A・提携動向(石油・ガス分野)
    Summary Resolute Energy Corporation (Resolute), a subsidiary of Resolute Holdings LLC is an oil and gas company that acquires and operates large-scale oil and gas properties. The company specializes in managing complex enterprise and undertakes complex transactions. It offers considerable acquisitio …
  • Petropavlovsk PLC:企業の戦略・SWOT・財務分析
    SummaryPetropavlovsk PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • ALPCO Diagnostics:企業のM&A・提携動向(医療機器分野)
    Summary ALPCO Diagnostics (ALPCO) imports and distributes immunoassay based products for life science markets. The company offers products such as immunoassays, flow cytometry reagents, chemiluminescent assays, recombinant proteins, purified antibodies, and HPLC and LC/MS-MS reagents. It also provid …
  • Spirit AeroSystems Holdings, Inc.:企業のM&A・事業提携・投資動向
    Spirit AeroSystems Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spirit AeroSystems Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Gemalto NV:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gemalto NV Mergers and Acquisit …
  • Kwang Dong Pharmaceutical Co Ltd (009290):企業財務及び戦略的SWOT分析
    Summary Kwang Dong Pharmaceutical Co Ltd (Kwang Dong) is a drug manufacturing company that develops, manufactures and supplies of pharmaceutical products, health drinks and supplements. The company’s pharmaceutical product includes Xelocan, Rosuridine, Atrazine, BEAUTAMIN injection, RIDBON tablets, …
  • Shizuoka Gas Company, Ltd. (9543):企業概要、財務及び戦略的SWOT分析
    Summary Shizuoka Gas Company, Ltd. (Shizuoka Gas) is a gas distributor. The company offers natural gas in China. Its gas is used in gas lamps, domestic cooking and heating, and industrial applications. Shizuoka Gas offers natural gas developed from coal and petroleum. The company provides safety ope …
  • China National Building Material Co Ltd:企業のM&A・事業提携・投資動向
    China National Building Material Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China National Building Material Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Continental Airlines, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Continental Airlines, Inc. Merg …
  • Shiseido Company, Limited:企業の戦略・SWOT・財務情報
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Tokai Pharmaceuticals Inc (TKAI):企業財務及び戦略的SWOT分析
    Summary Tokai Pharmaceuticals Inc (Tokai Pharma) is a biopharmaceutical company that develops and commercializes therapies for the treatment of prostate cancer and other hormonally-driven diseases. The company’s lead drug candidate, galeterone, an oral small molecule drug candidate which is intended …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆